Medical management of metastatic medullary thyroid cancer - Wikidata - thesis-toulmin - TriplyDB

Medical management of metastatic medullary thyroid cancer

Medical management of metastatic medullary thyroid cancer

http://www.wikidata.org/entity/Q27005897

about

Genetic and epigenetic factors affect RET gene expression in breast cancer cell lines and influence survival in patients.MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.Selective Ablation of Tumor Suppressors in Parafollicular C Cells Elicits Medullary Thyroid Carcinoma.Uncommon response of cisplatin and etoposide for treatment of advanced medullary thyroid carcinoma.Translational Diagnostics and Therapeutics in Pancreatic Neuroendocrine Tumors.Unusual gastric mucosal infiltration by a medullary thyroid carcinoma: a case report.Therapeutic effects of adenovirus-mediated CD and NIS expression combined with Na131I/5-FC on human thyroid cancer.Targeted Therapy for Medullary Thyroid Cancer: A Review.Detection of Molecular Alterations in Medullary Thyroid Carcinoma Using Next-Generation Sequencing: an Institutional Experience.Multimodal imaging with (18)F-FDG-PET/CT and (111)In-Octreotide SPECT in patients with metastatic medullary thyroid carcinoma.Sorafenib in the treatment of thyroid cancer.

P2860

Q37295706-2E4CF037-8023-4E7F-AEA2-F3622543F583 Q38719449-DF98B211-31D9-458D-9CA8-FF2FF69C0414 Q38719594-3A93F96C-EC25-4D80-9901-4D573F3B25D1 Q42279573-70F12205-C5E9-44BE-8417-C1851A9CD7DD Q42379480-69FE723F-DDCE-4C5C-BD56-BCE439D77717 Q42400842-583EA2AC-6DC3-4FBD-9AC4-33FA14E2EED3 Q49207200-50EB29E0-0414-4854-8B54-E6BE38810CD8 Q49328959-8F655A64-2E0A-4E86-A393-39E49D92B3C3 Q51662748-2B89C234-741D-49CA-AC4D-F8B165402D92 Q52985771-6BCA1786-47BF-4F2C-87AA-867842ADEFC3 Q55053748-E878582E-BADA-4166-B102-101CC0772CFE

P2860

Medical management of metastatic medullary thyroid cancer

http://www.wikidata.org/entity/Q27005897

description

2014 nî lūn-bûn

@nan

2014 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի նոյեմբերին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Medical management of metastatic medullary thyroid cancer

@ast

Medical management of metastatic medullary thyroid cancer

@en

Medical management of metastatic medullary thyroid cancer

@nl

type

label

Medical management of metastatic medullary thyroid cancer

@ast

Medical management of metastatic medullary thyroid cancer

@en

Medical management of metastatic medullary thyroid cancer

@nl

prefLabel

Medical management of metastatic medullary thyroid cancer

@ast

Medical management of metastatic medullary thyroid cancer

@en

Medical management of metastatic medullary thyroid cancer

@nl

P1433

Q27005897-0F1C5FF1-5C0C-4539-8B70-30E140E2B04A

P1476

Q27005897-7CE1CD99-2C81-4DE6-A4E8-CA0FAAFD7782

P2093

Q27005897-6D244FD4-F457-45EA-9F4E-9C61BC321060

P2860

Q27005897-00C4B836-3C8A-4206-ACF9-1DFA67217957

Q27005897-0295182C-58DF-4E0D-B6D9-236CCF4623DA

Q27005897-0425CB80-3099-4354-871E-B34126B4FEA3

Q27005897-05083D21-AC07-404C-AE87-8B49A59E9D48

Q27005897-0898B1EE-23A0-43F4-85F5-D3B16B3CBF3E

Q27005897-0B57384A-8ED4-44D4-A445-4764422264D9

Q27005897-13B342B0-D124-4DB5-9062-EB48B4304D78

Q27005897-15B848EE-12F4-4A5D-8012-B67822C3E79C

Q27005897-178B271E-AA2F-4F48-A5D0-CDE7ABD4EA6C

Q27005897-186AC6B9-9CFC-4A35-BA2F-73D57A1C7465

P304

Q27005897-9036E1D4-E542-427F-81CC-A54752A6F9C7

P31

Q27005897-DE2347DA-5509-4A7E-9115-E821085B2523

P3181

Q27005897-0AB95992-02E5-4A0F-93C1-7CD12BC5D94E

P356

Q27005897-65266092-87EA-4AFB-9B67-B4B10CA4050C

P407

Q27005897-363BFE84-5563-44FC-BF78-9B3E99D7E9D1

P433

Q27005897-7C0AFB00-3D72-49CA-8E59-F7EF4D4E7A34

P478

Q27005897-2646CB96-2DF2-42B7-ACAE-FDA7985CF1DE

P50

Q27005897-66777B33-DC55-4E7A-B900-1E1462846B93

Q27005897-7AD3506C-3103-4BA9-8913-7E4241B4F53D

Q27005897-A2D89578-5BB7-42CB-AF26-7128BB192303

P577

Q27005897-A0AF829A-022B-42DD-B8DD-74541E0E83F8

P5875

Q27005897-32622F41-4402-42DC-91A4-48132E137BF6

P698

Q27005897-AFC0A1C2-628C-4599-B3E6-A59618B97FAC

P932

Q27005897-60929F77-D5C6-491A-8831-86DADB92C987

P3181

P356

P1433

P1476

Medical management of metastatic medullary thyroid cancer

@en

P2093

Jessica E Maxwell

http://www.w3.org/2001/XMLSchema#string

P2860

Activation of RET as a dominant transforming gene by germline mutations of MEN2A and MEN2B

Thalidomide is an inhibitor of angiogenesis

A 1.5-megabase yeast artificial chromosome contig from human chromosome 10q11.2 connecting three genetic loci (RET, D10S94, and D10S102) closely linked to the MEN2A locus

Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer

BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: a systematic review and meta-analysis

Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study.

Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer

Mutations of the BRAF gene in human cancer

Mechanism of activation of the RAF-ERK signaling pathway by oncogenic mutations of B-RAF

Phase II trial of the antiangiogenic agent thalidomide in patients with recurrent high-grade gliomas

P304

3287-3301

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P3181

4291206

http://www.w3.org/2001/XMLSchema#string

P356

10.1002/CNCR.28858

http://www.w3.org/2001/XMLSchema#string

P407

P433

21

http://www.w3.org/2001/XMLSchema#string

P478

120

http://www.w3.org/2001/XMLSchema#string

P50

Scott K. Sherman

Thomas O'Dorisio

P577

2014-06-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

263290900

http://www.w3.org/2001/XMLSchema#string

P698

24942936

http://www.w3.org/2001/XMLSchema#string

P932

4268545

http://www.w3.org/2001/XMLSchema#string